Skip to main content
. 2018 Dec;9(6):1054–1062. doi: 10.21037/jgo.2018.07.05

Table 1. Patient characteristics.

ID Malignancy Gender Race Age (years) ECOG PS Initial stage Pathologic grade Number of metastatic sites Organ transplant Reason for transplant Years from transplant Donor type Cold/warm ischemia Ischemia time
1 HCC M White 56.8 IVA Moderately differentiated 2 Liver HCC 2.7 DCD Warm 27 min
2 Melanoma M White 54.5 1 IA Not assessed 3 Liver HCC 5.5 DDLT Cold 5 h 30 min
3 HCC M White 55.9 1 Not assessed 1 Liver HCC 7.8 DDLT
4 HCC F White 34.9 0 IIIB Moderately differentiated 2 Liver HCC 3.7 Living donor 3 h 24 min
5 HCC M White 63.6 1 I Moderately differentiated 2 Liver HCC 1.2 DDLT Cold 8 h 45 min
6 HCC M White 68 1 II Moderately differentiated 2 Liver HCC 1.1 DDLT
7 Melanoma M White 63.4 0 IB Poorly differentiated 4 Liver Cholangiocarcinoma 3.1 DDLT Cold 6 h 8 min
Median N/A N/A N/A 56.8 1 N/A N/A 2 N/A N/A 3.1 N/A N/A 4 h 27 min

–, denotes that data not available for evaluation. HCC, hepatocellular carcinoma; M, male; F, female; ECOG PS, Eastern Cooperative Oncology Group performance status; DCD, donor after cardiac death; DDLT, deceased donor liver transplantation; h, hours; min, minutes; N/A, not applicable; ID, patient identification.